Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems. 1981

R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai

The antitumor activity of 7-N-(p-hydroxyphenyl)-mitomycin C (M-83) was compared with that of mitomycin C (MMC) in rodent tumor systems. M-83 exhibited more potent activity than MMC against the ascitic form of lymphocytic leukemia P388 and fibrosarcoma Meth 1, and doses of over 5 mg/kg of M-83 (1/6 LD50) resulted in some 60-day survivors. The chemotherapeutic ratio (optimal dose/MED) of M-83 was around 64 and was estimated to be approximately 5 to 8 times higher than that of MMC. Upon intravenous administration, M-83 also gave a better survival and showed a higher chemotherapeutic ratio than MMC against intravenously implanted P388. M-83 inhibited the growth of solid form of sarcoma 180 to the same extent as MMC at an equivalent dose, but showed a higher safety margin than MMC. M-83 was as effective as MMC against Lewis lung carcinoma at dose levels giving the same degree of toxicity. In vitro studies on tumor growth inhibition demonstrated that the cytotoxic effects of M-83 against leukemia P388 and fibrosarcoma Meth 1 cells were similar to and stronger than those of MMC, respectively.

UI MeSH Term Description Entries
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas

Related Publications

R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
March 1985, The Journal of antibiotics,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
January 1982, Gan no rinsho. Japan journal of cancer clinics,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
September 1983, Gan no rinsho. Japan journal of cancer clinics,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
January 1984, Investigational new drugs,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
October 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
September 1984, Nucleic acids research,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
September 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
September 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
June 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
R Imai, and M Morimoto, and H Marumo, and T Kobayashi, and T Tsuruo, and M Inaba, and S Tsukagoshi, and Y Sakurai
August 1982, The Japanese journal of antibiotics,
Copied contents to your clipboard!